Dupont De Nemours Inc
NYSE:DD
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
61.21
89.54
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Earnings Call Analysis
Q3-2024 Analysis
Dupont De Nemours Inc
DuPont reported an impressive third quarter, achieving net sales of $3.2 billion, which represents a 4% increase compared to the previous year. This growth was attributed to a 3% rise in organic sales and a favorable portfolio impact from acquisitions, notably the Spectrum and Datatel acquisitions. Notably, there was a volume increase of 5%, which was slightly offset by a 2% decline in pricing. The capable recovery observed in various markets, particularly electronics, underpinned this performance.
In terms of segment performance, Electronics and Industrial (E&I) achieved an organic sales growth of 10%. The Water and Protection (W&P) segment showed signs of recovery with a decline in organic sales moderating to just 2%. Notably in the Asia Pacific region, sales saw a strong 9% growth primarily driven by solid demand from the Chinese market. The progress in these segments highlights DuPont's focus on high-demand sectors and improving operational efficiencies.
DuPont's Operating EBITDA for the quarter reached $857 million, marking an 11% increase year-over-year, with margins improving significantly by 150 basis points to 26.8%. The adjusted earnings per share (EPS) of $1.18 represents a stunning growth of 28% from the previous year's $0.92. Not just limited to operating earnings, DuPont exhibited strong cash flow management, generating transaction-adjusted free cash flow of $640 million, equating to a remarkable conversion rate of 130%.
Looking ahead, DuPont raised its guidance for the full year 2024. The company now forecasts an operating EBITDA of approximately $3.125 billion and an adjusted EPS of $3.90, reflecting a projected 12% year-over-year growth. This revision showcases confidence in sustained performance and solidifies the company's growth trajectory moving forward.
Management reiterated its commitment to the planned separations of its electronics and water businesses. They are now looking to expedite the timeline to potentially complete the separations towards the earlier end of the previously stated 18-24 month period. This strategic move aims to unlock distinct value for each business unit and align with tailored growth strategies geared specifically towards each sector's dynamics.
A significant factor behind the company's successful quarterly results was its operational excellence initiatives. DuPont reported robust progress in productivity improvement and cost management, mainly owing to restructuring actions taken in the previous periods. This includes an impressive training initiative with approximately 30,000 hours invested in employee development year-to-date. These efforts have been instrumental in mitigating the impact of inflation and operational costs.
While segmentantly the company is experiencing broad recovery, the E&I segment has noted a slight decline in pricing (down 1%), attributed to the introduction of newer products and the subsequent historical price adjustments typical in high-growth sectors. Management anticipates this price giveback trend will continue, reflecting the natural ebb and flow related to product lifecycle and market competition.
Looking into 2025, DuPont's management expects a continuation of growth in the semiconductor space driven by strong AI demand and new manufacturing capacities coming online, particularly in China. However, caution was expressed regarding the maturation of the memory market, which hasn't yet fully recovered. The expectation for W&P is equally optimistic, with continued recovery anticipated in healthcare-related markets, further stabilizing demand as we enter the new year.
Thank you for standing by. My name is Pam, and I will be your conference operator today. At this time, I would like to welcome everyone to the DuPont Third Quarter 2024 Earnings Conference Call. [Operator Instructions]
Thank you. I would now like to turn the conference over to Chris Mecray, Investor Relations. You may begin.
Good morning, and thank you for joining us for DuPont's Third Quarter 2024 Financial Results Conference Call. Joining me today are Ed Breen, Executive Chairman; Lori Koch, Chief Executive Officer; and Antonella Franzen, Chief Financial Officer. We have prepared slides to supplement our remarks, which are posted on DuPont's website under the Investor Relations tab and through the webcast link. .
Please read the forward-looking statement disclaimer contained in the slides. During this call, we'll make forward-looking statements regarding our expectations or predictions about the future. Because these statements are based on current assumptions and factors that involve risks and uncertainties, our actual performance and results may differ materially from our forward-looking statements. Our Form 10-K as updated by our current and periodic reports, includes detailed discussion of principal risks and uncertainties, which may cause such differences. Unless otherwise specified, all historical financial measures presented today are on a continuing operations basis and exclude significant items.
We will also refer to other non-GAAP measures. A reconciliation to the most directly comparable GAAP financial measure is included in our press release and presentation materials and have been posted in DuPont's Investor Relations website.
I'll now turn the call over to Lori, who will begin.
Good morning, and thanks, everyone, for joining our third quarter call. Earlier today, we reported another strong quarter of financial performance with continued sequential improvement across all key financial metrics. We posted a solid quarter highlighted by year-over-year growth for consolidated net sales, operating EBITDA and adjusted EPS. Third quarter sales of $3.2 billion included a return to organic sales growth which increased 3% versus the year ago period.
Operating EBITDA of $857 million increased 11%, with operating EBITDA margin increasing 150 basis points to 26.8%. Third quarter adjusted EPS of $1.18 increased 28% year-over-year. We also delivered another strong quarter of cash generation with transaction-adjusted free cash flow conversion of 130%, highlighting our disciplined working capital management. For the full year 2024, we are raising our guidance for operating EBITDA and adjusted EPS, which Antonella will detail shortly. From an end market view, the Electronics and Industrial segment saw another quarter of double-digit sales growth in both the semi and Airconnect Solutions lines of business, which continued to benefit from strong demand for advanced node chips and AI enabling technologies.
In the Water & Protection segment, we saw better-than-expected sequential improvement in water, including continued stabilization in China volumes. We also saw further sequential sales lift in medical packaging end markets, which are returning to more normalized buying patterns. Overall, I'm encouraged by our continued positive results. Volume recovery has been a key driver of our financial performance, coupled with our team's continued strong operational execution and helped by savings from the restructuring actions taken earlier this year.
I am pleased to say we have made real progress with our operational excellence initiatives with benefits seen in improved margins and working capital and enhanced customer reliability metrics. By fostering our culture of continuous improvement and equipping our teams with the right tools and training, we are well positioned to unlock long-term value across each business line.
Specific to the trading aspect we have been actively investing in our people and have completed around 30,000 hours of training year-to-date. We count on operational excellence to drive productivity every year as a key offset to inflation. Through focus on process optimization, we have successfully reduced costs across critical operations with benefits from increased uptime, leading to incremental capacity release and lower fixed and variable costs. All in, we are pleased to report a strong third quarter and are well positioned for a solid finish to the year.
I'll now turn the call over to Ed, who can provide a few comments around our progress on the planned separations on Slide 4.
Thanks, Lori, and good morning, everyone. We clearly remain focused on driving results and demonstrating the performance potential of our portfolio while also advancing our plans to unlock value through the previously announced separations of our electronics and water businesses. We remain excited about this value creation opportunity and believe our investors broadly appreciate the potential that we expect these 3 industry-leading companies to realize by leveraging tailored growth strategies.
Our teams remain highly motivated and have the experience to ensure that the new companies are prepared to operate and execute from day 1. We continue to make progress on our separation related work streams. We are also working diligently to accelerate our timing to potentially complete the separations closer to the earlier end of the 18- to 24-month time line set at our May announcement, and we'll update you as we progress. In addition, we are making progress in establishing the new ports, which have been a major focus of mine, and we expect to be able to announce Board members of each company, along with key executive leadership appointments for electronics and water by the end of the first quarter of 2025.
With that, I'll turn it over to Antonella, who will cover our financial results and outlook.
Thanks, Ed, and good morning, everyone. We are very pleased that our third quarter results reflect sequential improvement across all key financial metrics and a return to organic sales growth at the consolidated level. Both earnings and cash flow benefited from volume recovery and improved production rates at key operating sites and our team has executed well on productivity and cost actions announced last year.
Turning to Slide 5, I will cover our third quarter financial highlights in further detail. Net sales of $3.2 billion increased 4% versus the year ago period on organic sales growth of 3% and favorable portfolio impact of 2%, reflecting contributions from both the Spectrum and Datatel acquisitions. These increases were partially offset by a 1% currency headwind. The organic sales growth of 3% reflects a 5% increase in volume, partially offset by a 2% decrease in price. Higher volume was driven by continued broad-based growth in electronics end markets with semi and Interconnect Solutions volumes both up double digits, coupled with the return to year-over-year volume growth in Water Solutions.
On a segment view, E&I organic sales grew 10%, and W&T's quarterly organic sales decline moderated further to 2% on its way to an anticipated return to positive growth in the fourth quarter. Organic sales in corporate declined 6% versus the year ago period driven by continued weakness in China solar markets, which led us to exit a photophotolic film product line during the third quarter. This product line represents less than 1% of consolidated [indiscernible].
From a regional perspective, Asia Pacific delivered 9% organic sales growth versus the year ago period, led by another strong quarter in China, where organic sales were up low double digits, driven by electronics end markets. In other regions, organic sales in Europe grew 1%, while North America was down 2%. Second quarter operating EBITDA of $857 million increased 11% versus the year ago period as volume gains along with improved plant utilization and savings from restructuring actions were partially offset by higher variable compensation and select growth investments.
Operating EBITDA margin during the quarter increased to 26.8%, up 150 basis points versus the year ago period and up 160 basis points on a sequential basis. Third quarter reflected another period of strong cash generation and conversion, reflecting both improved volumes as well as strong working capital discipline across each business line. On a continuing operations basis, cash flow from operations of $737 million, less capital expenditures of $109 million and $12 million of separation-related transaction cost payments resulted in transaction-adjusted free cash flow of $640 million and related conversion of 130%.
Turning to Slide 6. Adjusted EPS for the quarter of $1.18 per share increased 28% from $0.92 in the year ago period. Higher segment earnings of $0.14 as well as the benefit of a lower share count of $0.09 and lower tax rate of $0.6 were partially offset by higher depreciation of $0.03. Our base tax rate for the quarter was 19.8%, down from 24.6% a year ago, driven by [indiscernible] tax benefits recorded in the current period. We now estimate our full year 2024 base tax rate to be approximately 23.5%.
Turning to segment results, beginning with ENI on Slide 7. ENI third quarter sales of $1.6 billion increased 13% versus the year ago period, had organic sales growth of 10% and the spectrum in Datatel sales contribution of 4% were slightly offset by a 1% currency headwind. Organic sales growth of 10% reflects an 11% increase in volume, slightly offset by a 1% decrease in price. As the line of business level, organic sales per study were up more than 20% for the second consecutive quarter, reflecting continued overall semi demand recovery driven by AI technology ramps and share gains in certain products.
Semi demand was [indiscernible] in China including continued customer prebuying, similar to what we saw last quarter. As we move forward, we expect China demand to normalize but still remain strong. Overall, Semi-fab utilization continues to improve, averaging 76% during the quarter, though notably stronger for advanced node chips due in part to AI-related demand acceleration. Interconnect Solutions delivered another strong quarter as well, with organic sales up low double digits, reflecting continued broad-based electronic recovery, including a demand benefit from AI-driven technology ramps.
We saw content and share gains within high-value electronics applications and the volume recovery within the overall [indiscernible] space. The year-over-year sales decline in Industrial Solutions continued to moderate as organic sales were down slightly during the quarter. and strength in printing and packaging applications was offset by ongoing volume headwinds for coverage. Also within Industrial Solutions, we completed the acquisition of Donaco, a medical device manufacturer at the end of August. We are very pleased with the integration of Datatel into spectrum and are seeing the potential benefit to leverage [indiscernible] technology and capabilities to other businesses as well as cross-selling opportunities within our health care platform.
Operating EBITDA for ENI of $467 million was up 22% versus the year ago period driven by volume growth, the impact of higher production rates, savings from restructuring actions as well as the earnings contribution from Spectrum and [indiscernible]. These gains offset by higher variable compensation and select growth investments related primarily to the ongoing transition to advanced nodes and new and ramping AI applications across to semi and interconnect solutions.
Operating EBITDA margin during the quarter was 30.4%, up 210 basis points versus the year ago period. Turning to Slide 8. W&P third quarter net balance of $1.4 billion declined 2% versus the year ago period primarily due to price headwinds as overall segment volumes were flat. Within Safety Solutions, Organic sales were down mid-single digits, largely on price declines, although with lower volume driven mainly by private medical packaging. We did see a second consecutive quarter of sequential sales growth in medical packaging with sales up 10% in Q3.
Shelter Solutions sales were down slightly on an organic basis with headwinds in North American residential construction market, mostly offset by growth in commercial construction. The third quarter is it a return to year-over-year sales growth for Water Solutions where organic sales were up low single digits. Higher volumes were driven by strength in ultrafiltration technologies along with continued volume recovery in China. On a sequential basis, Water Solutions sales also increased for our second consecutive quarter with sales up 3%, which was better than our expectations coming into the quarter.
Operating EBITDA for W&P during the quarter of $364 million was up 1% versus the year ago period as productivity and savings from restructuring actions more than offset the organic revenue decline and higher variable compensation. Operating EBITDA margin during the quarter was 26.3%, up 70 basis points from the year ago period. As alluded to the fourth quarter, we expect strong volume growth on a year-over-year basis.
Moving to our outlook on Slide 9. For the fourth quarter, we expect net sales, operating EBITDA and adjusted EPS of about $3.07 billion, $719 million and $0.98 per share, respectively. On a year-over-year basis, our fourth quarter guidance has been sales and earnings growth from both E&I and WMP, translating to total company growth in net sales of about 6%. Operating EBITDA of 10% and adjusted EPS of 13%. Sequentially, we assume normal seasonal declines in our electronics and construction markets. Additionally, as I mentioned earlier, we expect to see a moderation of growth in China as free [indiscernible] semi plays out as well as the impact of the sitting with a PD [indiscernible].
Partially offsetting these sequential declines is the continued recovery in water and medical packaging end markets. For the full year 2024, we are raising our earnings guidance above the high end of our prior range and now expect operating EBITDA of about $3.125 billion and adjusted EPS of $3.90 per share, which reflects 12% EPS growth year-over-year. With that, we are pleased to take your questions, and let me turn it back to the operator to open the Q&A.
[Operator Instructions] And the first question comes from the line of Steve [indiscernible] from JPMorgan.
Our next question comes from the line of Scott Davis from Melius Research.
Congrats on the quarter. And I wanted to come back to your comments on the -- it looks like the bid ask on the 18 to 24 months has narrowed down a bit. But what are the work -- you put the work streams on Slide 4, 6 of them. But like what are the gating factors? Kind of why do you feel a little bit more comfortable today perhaps than 3 months ago in that time frame getting short.
Yes. Yes, we've made great progress. Two of the longer poles in the tent of the legal entity work and the IT work to separate everything, and the teams have made tremendous progress on that. So our confidence level is definitely up, and that's why we made the comment that we might be more on the 18-month time line somewhere and maybe in that ZIP code, which if we could get it all the way to that would be December 2025. So we'll keep you posted on that. we're pretty positive. We're going to move it in. The issue is can we move it in all that way.
Okay. Fair enough. And guys, the electronics business, the prebuy that you've talked about that the last 2 quarters. What -- why is there -- I guess maybe I can get to back up a little bit, why is there a prebuy? Why are they concerned about not having enough or are you not being able to supply enough product on time. Why do they want to build inventory, I guess?
Yes. So a lot of it ties around the. Yes. So a lot of it, Scott, is around the new fabs that are being put in place in China. So last quarter, we had mentioned $30 million in total, $20 million of which was in [indiscernible]. This quarter is another $20 million for a total of $40 million over the second half. And it's really the new fabs coming online. So about half of the global fabs that are being constructed are in China, there's about 7 of them for intologic space and 3 in the memory space. And as they bring their new fabs online, they prebuy to get through qualifications in the ramp. So it's really a function of fact from the prebuy perspective that we had quoted.
That's what happens when you're not a tech analyst. I had no idea. Thank you. .
Your next question comes from the line of Steve Tusa from JPMorgan.
Just a lot going on today, I guess. Can you just talk about the trends you saw in exiting September and October, just for broadly the various businesses in the portfolio? Anything move around materially?
No. minus the normal seasonality that you see in the quarter with the last month being the strongest primarily in the water space, there wasn't a lot of variability as we exited the quarter. I mean as we go into the fourth quarter, we have the usual seasonal sweetness that we see primarily within the electronics space and the shelter space. And as you recall, we had done on the last earnings call, we had mentioned that the recovery kind of came early and the seasonality that you normally would see from 2Q to 3Q was a little muted. And therefore, do you see the seasonality as you head into the fourth quarter, you have to compare the fourth quarter to the second quarter, and that's where you see that about $100 million that we typically see between the electronics and the shelter space.
Okay. And then in the W&P margins, anything unusual there, really strong margins in the quarter? And anything going on there? Any raw material relief or maybe price cost, something like that?
Yes. We were really pleased with the margins that we saw. It's a lot of operational execution that we've been driving across the whole company. So we took a lot of restructuring actions earlier this year. We're seeing the benefit of those -- we're driving productivity and operational excellence. We shuttered a couple of lines -- older lines in the U.S. in the safety business that are nicely impacting our broader profile. So we're encouraged by the 26% plus that we posted .
So that should be able to leverage nicely as volumes come back, I would assume.
Yes. .
Your next question comes from Chris Parkinson from Wolfe Research.
Just want to dig in a little bit more into the semi tech side of it. I mean, clearly, you have some benefits from some of the Chinese subs. But -- can you just dig in a little bit more by product substrate in terms of the pad slurries? It just seems like there's a bit of a bifurcation between some of the product categories versus others based on what evolving in the marketplace. So any color there would be particularly helpful.
Yes. I mean we saw strength across all the key semi technologies. So within the CMP space with pads and slurries within the listed space, we saw really nice results in the [indiscernible] space. So it's a combination of one, the market recovery from the destock that happened last year. Two, the strength that we have in China. So we are a larger footprint in China than some of our peers, and that's where a lot of the new fab construction is going on a lot outsized recovery is happening. And then our exposure to advanced nodes versus the legacy nodes and DRAM versus memory is driving our results. So we had been up 50% plus in China. So that was a key driver of the overall sentiment results being up in the low 20% range. .
That's helpful. And just as a follow-up on the W&T side, you've got some things going pretty well, but it still seems like the macro is overall a little bit sluggish. So -- just digging to the water side of it, can you hit on kind of the drivers of the ultrafiltration strength? It seems like China is kind of beginning to turn the corner. Just how we should ultimately be thinking about that? Is this now back to normalization as we kind of get into 2025? Or are there any other considerations we should be looking at?
Yes. We should start to see activity more normalized now. I think we're clearly past the worse of it. We've seen sequential improvement from the first quarter to the second quarter. We saw it again going into Q3. And and we would expect we continue to see some sequential improvement as we move into Q4. So overall, the business has definitely gotten back to where -- getting close back to where we used to be. I would tell you, the activity in China has improved, the ultrafiltration activity, in particular, just in any one region to call it out, but we're definitely seeing much better activity overall in water and have kind of passed the destock.
Your next question comes from Vincent Andrews from Morgan Stanley.
Maybe just one more item of something that needs to turn the corner a little bit is the Caleres destocking. Are you sort of at the bottom of that? And should we start to see that inflect?
Yes, we're definitely at the bottom. We actually saw a sequential improvement. We're still seeing year-over-year headwinds. So we expect the business to continue to stabilize and see recovery as we head into 2025. So just a reminder of the [indiscernible] end markets, it is largely semi-CapEx exposed. So the long-term profile and expectations for topline growth in that business are very sound as there continues to be an expectation of mid-single-digit capacity expansions within the semi space.
And then I'd be curious to get your thoughts on interest rates. I think we've all been sort of poised and waiting for these cuts and they're kind of starting to happen, but the the curve is not sort of behaving the way I think we all thought it would and that the back end has kind of stayed high and the front end has come down. So maybe you could just talk about if rates do get cut, which parts of your businesses will benefit the most from the front end coming down versus which parts really need the back end to come down?
Yes. I mean, on the front end, it would be the construction market, primarily the North America residential space. And so we had mentioned in our 4Q expectations that they're a little needed in the shelter space because the rate cuts didn't happen quickly. And as we'll see what happens here at the next meeting the expectations through the fine cut again. But I would say that front's our largest exposure with respect to positive using breakout slide down, more broadly, obviously, the lower rate covers broader economic activity that will favor all of our businesses.
Your next question comes from Josh Spector of UBS.
I wanted to ask on not necessarily the spin time line per se, but really, are there alternatives still being explored for any of the businesses, water or electronic outside of the spins be it the sale or RMT? And just if you are, how do you think about maybe achieving something there versus the spin time line? What would be more important to you?
Yes. No, it's a little simpler than that, Josh. Our plan is to do the separation of both water and electronics, and we're moving very rapidly down that growth. As we mentioned on the prepared remarks, we're talking to potential Board members already. We making 4 announcements for the companies and management announcements for those companies during the first quarter of next year.
Okay. Clear enough. And on the core business, I wanted to ask about -- you had some comments about increased investments, increased variable comp. Obviously, some of that makes sense given the better operating performance. But I was wondering if we think about the level of investment taking place now, is that fully back to normal in that if we look at growth, the incrementals become higher as we look forward -- or are you still investing at a lower level given demand remains tepid.
Yes. I mean we're not going gangbusters, right? So we had some growth investments primarily within the electronics space as we look to continue to take advantage of the AMI recovery. And we had mentioned the variable compensation headwinds and you can see in our approximately about from last year and variable compensation within an average of 15% payoff, so that would be as been as we had 2024. We continue to keep button down until we're really confident that we've got recovery [indiscernible] to make CapEx levels at the same levels where they were last year and we'll continue to expect to revise this down expect we can below the 5% level comp.
And I wouldn't expect any outsized investments. We continue to be really smart. One of the key areas, I think, that's driving the margin profile that we're seeing and we did take a lot of actions, especially on the plant fixed cost front as we saw the volumes decline last year, and we've done a really nice job keeping those out even as volumes have recovered. So that's also driving a piece of our margin recovery.
Your next question comes from John Roberts of Mizuho.
Is China about 50% of the electronic sales and how much of that would be made in China for China as opposed to imported into China and might have some risk from some trade retaliation by China.
Yes. So China is about 30% of electronic sales. So about half of that is China for China and the other half does any come back out for global consumption.
Okay. And then how is advanced mobility looking with the slowdown in both EVs and ICE vehicles outside of China?
Yes. So we continue to see nice performance within the CEB side. We just got a really nice long term being with 1 of the large European OEMs within the bad space. So it is muted to growth expectations just as everybody else is with respect to VI revising down their expectations for total sales across the space, but we continue to be encouraged more broad based and longer-term transition.
Your next question comes from Aleksey Yefremov of KeyBanc.
Interconnect, could you discuss 2 things: The share gains that you cite -- and then the AI-driven ramps, what products are you seeing ramping in AI? What kind of applications.
Yes. On the AI side, in the packaging space within the interconnect business. So we're seeing nice improvement there. And on the share gain side, it's also it's a function of being greater share of wallet with some of our customers as we expand beyond just the phones and some of the other devices that our key customers are producing. So pleased with the results there.
We had mentioned, I think, on the last call about a lot of the [indiscernible] driven by thermal management and packaging opportunities, and that continues to play out.
Your next question comes from David Begleiter of Deutsche Bank.
Lori, E&I margins were above 30% in the quarter. Is that level sustainable for the entirety of 2025?
Yes. We've seen nice margin growth in both segments, both E&I and W&P. It's a little early to talk about specifics of 2025 at this point, but we are encouraged. There's not one time is driving that number, I'll say from that perspective. So as long as you can maintain the top line numbers that we're posting and the productivity initiatives should stay in place that we're driving, and we should be in an acquisition to get factored margin profile for the [indiscernible].
Very good. And just in Safety Solutions, what's driving the decrease in pricing?
So I think it's important to keep in mind that when you look over the last couple of years, particularly in some select businesses, we did have price increases that were in the mid-teens, which more than covered our cost increase. And so it wouldn't be too surprising that we would give back a couple of points in order to maintain share as we go forward.
Your next question comes from Frank Mitsch of Fermium Research.
Nice results. I want to say on the price -- I want to stay on the pricing area. And E&I, price was down 1%. Volumes were very impressive, but price was down a percent. You have to go back to the second quarter of last year when you saw price flat since then it's been ticking down. Can you expand upon what's driving the lower price and what your outlook is there?
You look specifically at E&I,to your point, typically, there is about a point of price giveback. A lot of it relates to new products kind of coming into the market. and volumes going up. So there's typically about 1 point in price historically what we see in E&I. And we would expect that trend to continue as we go forward.
Got you. So as you're pricing new products, you're giving discounts to the customers?
No. You're getting price on the new product introduction, Frank, but you get paid a little bit of price gain on older products which are -- that's very typical of the electronics business like that. Forget the last couple of years has been creating times with COVID and destock and all that, but that's typically been the model to a higher growth business more up in the mid- to high teens, but you give up about 10% of price. .
All right. Understood. And just on the restructuring benefits, I believe the last time you mentioned it was going to be about $115 million benefit in 2024. Is that still a good number? And any initial thoughts on 2025?
Yes. Actually, that benefit number is a bit higher. We got to our quarterly run rate of benefits in the third quarter. So we are getting a nice impact to this year. There will be a little bit of carry forward as we go into 2025.
Your next question comes from Mike Sison of Wells Fargo.
Nice quarter and outlook. Ed, a lot of the chemical companies thus far have kind of painted an exciting picture for the first half of '25 and maybe '25 in total. As you've noted, your end markets are different. So I know it's a little bit early to get specific outlook for 2025, but could you sort of give us your thoughts on how maybe semiconductors, electronics and some of the water and industrial businesses shape up for next year? .
Yes. I'll let Lori walk you through some detail just I don't mean this [indiscernible], but to make a comment, we really worked the portfolio very differently than we were 5, 6, 7 years ago away from chemical company into a multi-industrial. And I think you see that a lot of our end markets that we're in right now. But [indiscernible], maybe walk you through some puts and takes.
Yes. No, there's no significant changes from the commentary we had provided on the last call about some initial 2025 expectations. So from an electronics perspective, we continue to expect [indiscernible] growth to accelerate, really driven by the AI and the new fabs coming online. And just a reminder that the memory market and some of the more mature technology markets haven't recovered yet. So that recovery is on the come as we head into 2025. There's also on the interconnect side, continued utilization the PCB space, especially as you look for a refresh cycle within the AR space and consumer devices. Within W&P, we expect Timex Healthcare to continue to recover. As we had mentioned, we saw a sequential lift from Q2 to Q3 of 10%. We expect a further sequential [indiscernible] and then normalized buying has as we head into 2025. And we expect a more normalized demand environment within [indiscernible], we'll expect to continue to recover as well. So no changes from what we said last year or last quarter with respect to 2025. .
Your next question comes from Patrick Cunningham of Citi.
Are you still anticipating price givebacks in shelter in 4Q and maybe into 2025? And what was the dynamic between positive growth in commercial construction versus resi? And any sort of early view on a broad-based resi recovery into next year?
Yes. Given what we saw in pricing this year and as we're exiting the year, you would expect that you would have some price give back carryforward going into 2025. But I think the one thing that you got to keep in mind is we still have to take a deep look at where our [indiscernible] next year relative to a logistics and utilities and that to determine if there's any pluses or minuses associated with them. So I would expect that as we go forward.
In terms of the resi as a construction market, they are -- we are seeing a little bit less activity than what we originally anticipated. As Lori mentioned earlier, when you look at kind of rates and where they are, there were a few rate cuts that were expected in 2024. I mean we had one, so we had a little too late in the building cycle to really have an impact. So as we go in the next year, I would say, in terms of the construction markets, we would expect low single-digit activity, and I think that, that's kind of predicated on some additional rate cuts coming. But we'll see what happens.
Our current midpoint of guidance in the fourth quarter seemed slightly less price impact than we saw during the third quarter. .
Understood. Very helpful. And then just on consolidated W&P, I mean it seems you have easier comps on water, medical packaging. Is most of that sequential EBITDA decline come from more typical seasonality on shelter and safety. And if you could remind us what was the $25 million discrete impact from last year, and that won't repeat this year just for clarification.
Yes. So the Q3 to Q4 in W&P would be your typical seasonality. Q3 tends to be the highest quarter and comes down a bit. in Q4, a big piece of that would be related to the shelter business as we kind of go into the winter months. for [indiscernible] explicitly, we did call out about $25 million of onetime items last year that were related to a land sale and some supply agreements that we had certainly benefits from, I would say. Keep in mind that in totality, in Q4 of last year, we actually called out $40 million of onetime items that were [indiscernible] $15 million [indiscernible] in corporate. .
Your next question comes from John McNulty of BMO Capital Markets.
This is Bhavesh Lodaya for John. Can you talk about some of the competitive dynamics around your electronic peers in China. China is bringing in a lot of new fabs, as you mentioned, but they also invest in kind of like a homegrown domestic supply chain. You mentioned gaining some market share, I'm not sure if that was in China as well. But overall, how do you see this landscape developing over the next few years?
Yes, we can continue to have a nice position within China. I think our exposure in China within the semi spaces outside versus some of the peers. So we're about 30% in China, where some of the peers I think are left and that you're seeing that, that is fairly to play out nicely in our numbers as a lot of the bills are more concentrated there with respect to the global outlet. We have a nice position with the local players. As we had mentioned, we able to have nice positions with the global OEMs that are in China that are favoring our China results as well.
Your next question comes from Arun Viswanathan of RBC Capital Markets.
Just wanted to go back to maybe some initial thoughts on '25. So this year, you showed -- it looks like you're showing pretty good mid-teens EBITDA growth in E&I, although you have been -- that's been offset slightly by some of that water destocking and headwinds. As you look into next year, maybe if you adjust for the prebuy that you saw in E&I, would that kind of decrease maybe to like a high single-digit rate and then -- but maybe you could see some recovery in W&P, and so overall, you still expect maybe mid- to high single-digit EBITDA growth for next year? .
So that's where I provided some color on the top line. That's where our expectations are. I would say it's a bit too early to start commenting on EBITDA growth for next year. We'll give more detailed guidance as we get on to the next quarter call. But clearly, volume will be a driver as we noted this year, you would expect to have the continued benefits of our restructuring actions that we took this year to continue to benefit us as we move forward.
Okay. I understand. And just on that note then, assuming that you do see some continued margin growth, how should we think about free cash flow and maybe how you deploy that. Are there any significant extra CapEx projects in in the pipeline? Or will you likely be using most of your cash for standing up the businesses? And -- or could you potentially deploy more and return more to shareholders?
Yes. So I've been talking about free cash flow conversion. As I mentioned for this quarter, we did have a really strong free cash flow conversion. It was about 113%. We're at 109% for the year, and we did know -- we do expect to be well above our target for this year. As we go into next year, I would expect that we continue to have good free cash flow conversion. The teams have done a great job relative to managing working capital even while sales are increasing and we're now having a use of working capital.
As you think about our cash deployment for next year, given it is the year of the separation, the majority of cash will be used for our separation costs. We did know last quarter on the call, we do not expect to do any additional share repurchases this year. I would say that applies to next year as well and no significant outsized CapEx that you should be expecting next year relative to this year.
Your next question comes from Mike Leithead of Barclays.
I think DuPont filed an ITC complaint last month around a legal tieback imports, I guess, first, is the issue you're seeing somebody else claiming and naming something to be tied back and it's not -- or did it name something else and the issue is they're using DuPont's proprietary technology? And then just more broadly, how is the tieback business performing today?
Yes. So the ITC filing speak for itself. We'll continue to defend our patents and our trade secrets. So that's really all we want to say on that point. The [indiscernible] business from a end market performance continues to recover nicely. A lot of the headwinds that we had saw throughout 2024 was related to medical packaging, and we've highlighted a few times about a nice recovery that we're seeing there, up 10% sequentially and up even further sequentially as we head into Q4. So we're really encouraged by the rebound that we're seeing there.
And your last question comes from Steve Byrne of Bank of America.
Yes. I'd like to ask another one about that ITC complaint. When did you start to see these competing versions of Tyvek coming into the states? And is this across your broad platform? Is this this Tyvek house rep? Is this packaging? Is this PPE? Is it all of them? And you're seeing this this competing version? When did this happen? And just curious on the timing of this.
Yes. So I mean we had mentioned that the filing speak for itself as the public filing that can be red. So we started seeing it in recent months, the release of our [indiscernible] in addition to some trade infringement or as you were seeing, which is what led us to the [indiscernible].
And then maybe just one more across new DuPont any new products in development that you could be enrolling that could drive growth in new DuPont other than just the recovery in end markets.
Yes. So I have mentioned earlier that the really nice one that we saw in the battery adhesives space was 1 of the largest European OEMs. So that was a nice win for us that can to solidify our position in the EV space. We have a really nice growing position within health care. So we closed the Sonatel acquisition in August. We were actually out there [indiscernible] the Board visiting the site and we're even more encouraged by what we saw with respect to cross-selling with some of the larger medical device layers as well as leveraging the really high-end machining capabilities that Donnatal has, not only our medical packaging businesses that are other parts in the [indiscernible] portfolio. So really encouraged that, that space will continue to be a nice growth driver for us.
There are no more questions. I will now turn the conference back over to Chris Mecray for closing remarks.
Thank you, everyone, for joining the call. And for your reference, a copy of the transcript will be posted on our website. This concludes the call. Thank you.
Thank you all for joining. You may now disconnect.